Global Subcutaneous Infusion Pumps Market Growth 2025-2031
Description
The global Subcutaneous Infusion Pumps market size is predicted to grow from US$ 3965 million in 2025 to US$ 5597 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Subcutaneous infusion pumps are medical devices designed to deliver fluids, medications, or nutrients directly into the subcutaneous tissue (the layer of fat and tissue just under the skin) in a controlled and continuous manner. These pumps are typically used for long-term therapies and are programmed to provide precise dosages over extended periods, improving patient convenience and adherence. Commonly administered substances include insulin (for diabetes), opioids (for pain management), and immunoglobulins (for immune disorders). Subcutaneous infusion pumps can be either wearable or portable, and are favored for their minimally invasive nature, reduced risk of infection compared to intravenous routes, and ability to support outpatient or home-based care.
Subcutaneous infusion pumps typically feature programmable flow rates ranging from 0.025 mL/hour to 50 mL/hour with delivery accuracy of ±5–15%. They support both continuous (basal) and on-demand (bolus) dosing, with reservoir capacities varying from 1.8 mL (insulin pumps) to over 100 mL (for pain or immunoglobulin therapy). Most pumps use either rechargeable lithium-ion batteries (lasting 3–7 days) or disposable batteries in patch-style devices. Infusion sets often include soft or steel cannulas (6–13 mm in length) with tubing lengths up to 110 cm and angled or straight insertion options. Advanced models integrate Bluetooth or RF connectivity for app-based control and closed-loop operation with CGMs, while built-in safety features include occlusion alarms, low reservoir alerts, and automatic shutoff mechanisms.
LP Information, Inc. (LPI) ' newest research report, the “Subcutaneous Infusion Pumps Industry Forecast” looks at past sales and reviews total world Subcutaneous Infusion Pumps sales in 2024, providing a comprehensive analysis by region and market sector of projected Subcutaneous Infusion Pumps sales for 2025 through 2031. With Subcutaneous Infusion Pumps sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subcutaneous Infusion Pumps industry.
This Insight Report provides a comprehensive analysis of the global Subcutaneous Infusion Pumps landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Subcutaneous Infusion Pumps portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Subcutaneous Infusion Pumps market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subcutaneous Infusion Pumps and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subcutaneous Infusion Pumps.
This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Infusion Pumps market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Continuous Infusion Pumps
Bolus-enabled Pumps
Programmable Pumps
Segmentation by Application:
Diabetes Management
Pain Management
Immunodeficiency Treatments
Hormonal Therapy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Insulet
Tandem Diabetes Care
Medtronic
Beta Bionics
Ypsomed
SOOIL Development
ICU Medical
Baxter
Smiths Medical
Roche
Debiotech
Valeritas
Key Questions Addressed in this Report
What is the 10-year outlook for the global Subcutaneous Infusion Pumps market?
What factors are driving Subcutaneous Infusion Pumps market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Subcutaneous Infusion Pumps market opportunities vary by end market size?
How does Subcutaneous Infusion Pumps break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Subcutaneous infusion pumps are medical devices designed to deliver fluids, medications, or nutrients directly into the subcutaneous tissue (the layer of fat and tissue just under the skin) in a controlled and continuous manner. These pumps are typically used for long-term therapies and are programmed to provide precise dosages over extended periods, improving patient convenience and adherence. Commonly administered substances include insulin (for diabetes), opioids (for pain management), and immunoglobulins (for immune disorders). Subcutaneous infusion pumps can be either wearable or portable, and are favored for their minimally invasive nature, reduced risk of infection compared to intravenous routes, and ability to support outpatient or home-based care.
Subcutaneous infusion pumps typically feature programmable flow rates ranging from 0.025 mL/hour to 50 mL/hour with delivery accuracy of ±5–15%. They support both continuous (basal) and on-demand (bolus) dosing, with reservoir capacities varying from 1.8 mL (insulin pumps) to over 100 mL (for pain or immunoglobulin therapy). Most pumps use either rechargeable lithium-ion batteries (lasting 3–7 days) or disposable batteries in patch-style devices. Infusion sets often include soft or steel cannulas (6–13 mm in length) with tubing lengths up to 110 cm and angled or straight insertion options. Advanced models integrate Bluetooth or RF connectivity for app-based control and closed-loop operation with CGMs, while built-in safety features include occlusion alarms, low reservoir alerts, and automatic shutoff mechanisms.
LP Information, Inc. (LPI) ' newest research report, the “Subcutaneous Infusion Pumps Industry Forecast” looks at past sales and reviews total world Subcutaneous Infusion Pumps sales in 2024, providing a comprehensive analysis by region and market sector of projected Subcutaneous Infusion Pumps sales for 2025 through 2031. With Subcutaneous Infusion Pumps sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subcutaneous Infusion Pumps industry.
This Insight Report provides a comprehensive analysis of the global Subcutaneous Infusion Pumps landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Subcutaneous Infusion Pumps portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Subcutaneous Infusion Pumps market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subcutaneous Infusion Pumps and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subcutaneous Infusion Pumps.
This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Infusion Pumps market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Continuous Infusion Pumps
Bolus-enabled Pumps
Programmable Pumps
Segmentation by Application:
Diabetes Management
Pain Management
Immunodeficiency Treatments
Hormonal Therapy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Insulet
Tandem Diabetes Care
Medtronic
Beta Bionics
Ypsomed
SOOIL Development
ICU Medical
Baxter
Smiths Medical
Roche
Debiotech
Valeritas
Key Questions Addressed in this Report
What is the 10-year outlook for the global Subcutaneous Infusion Pumps market?
What factors are driving Subcutaneous Infusion Pumps market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Subcutaneous Infusion Pumps market opportunities vary by end market size?
How does Subcutaneous Infusion Pumps break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
119 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Subcutaneous Infusion Pumps by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Subcutaneous Infusion Pumps by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
